Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Health - January, 2005
27 articles
- FDA Rejects J&J Petition, OKs Duragesic Generics
- Teva Wins Appeal Over Merck's Fosamax Patent
- Brazil Renews Threat To Break Patents On HIV/AIDS Drugs
- Judge Assigns Joint Inventor To Visudyne Patent
- AstraZeneca Faces New Class-Action Suit Over Prilosec Patent Expiration
- Judge Overturns $35M Jury Award In Georgia Trademark Case
- Ranbaxy Rules Out "At-Risk" Lipitor Launch: Report
- In Blow To Barr Pharma, Appeals Court Affirms Wyeth Victory In Trade-Secrets Case
- Genzyme Sues TKT Over Biotech Patent In Israeli Court
- WHO Endorses Compulsory Licensing Of Anti-Flu Patents
- European Patent Office Upholds Angiotech's Patent For Drug-Coated Stents
- Eon Challenges Pfizer's Patents For Zithromax
- Court Refuses To Reclassify Allergan's Restasis As Non-Antibiotic
- Federal Circuit Rules For Pfizer In Teva's Challenge To Zoloft Patent
- Mergen, Oxford Gene Technology Settle Patent Infringement Suit
- In Setback For Glaxo, European Court Clears Paxil Generics
- Trial Opens In Glaxo's Lamictal Patent Suit
- Shire Sues Impax Again Over New Adderall ANDAs
- St. Jude Medical To Pay $5M To Settle Edwards Patent Suit
- U.S. Supreme Court To Hear Merck v. Integra
- Geron Wins Patent Interference Over Cloning Technology
- Judge Deals Blow To Medtronic In Case Over Heart-Stent Patents
- Judge Rules Against Teva In Case Over Generic Univasc
- Andrx To Exit Brand Business, Focus On Generic Drugs
- Australian Medical Device Maker Sues U.S. Rival Over Cardiac Device Patents
- In Policy Overhaul, India Allows Drug Patents
- In Setback For Mylan, Judge Upholds Levaquin Patent